Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Vintafolide in Solid Tumors
NCT01002924Phase 2Completed
- Sponsor
- Endocyte
- Start
- Dec 2009
- Primary completion
- Dec 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of vintafolide in solid tumor, sponsored by Endocyte. Started Dec 2009; status: completed.
02
Drugs
vintafolide
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01002924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002924.